The intellectual property will enhance Liberate Bio’s LNP platform for selective programming of monocytes and macrophages.

Why do diabetic wounds refuse to heal? A new scientific review highlights how disruptions in the timing and behavior of ...

Liberate Bio, Inc., a biotechnology company developing genetic medicines that deliver RNA therapies directly to immune cells, announces that it has secured exclusive and non-exclusive licenses to key ...

Hormone-regulated immune cells produce IL-10 to resolve pain more effectively in males, offering a potential new target for non-opioid chronic pain treatments.

Scientists have uncovered a powerful genetic switch that helps some of the body’s most important immune cells grow up properly and keep our organs healthy. The switch, called MafB, guides immature ...

For decades, differences in pain between men and women have often been attributed to psychological, emotional or social ...

Researchers at the University of Liège have identified a key genetic regulator that enables macrophages to reach full ...

A specific subset of immune cells driven by testosterone resolves pain faster in men, explaining why women are more likely to ...

A new study in Science Immunology has proven the exact reason why women feel chronic pain differently. Here is why it matters for Indian women and how it could pave the way forward for targeted ...